<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24294731</identifier>
<setSpec>0034-0634</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Carreras Delgado, José Luis</dc:author>
<dc:description xml:lang="en">The Diffuse Large B-Cell Lymphoma is the most frequent non Hodgkin Lymphoma. The role of CT/PET in this relatively homogeneous group of lymphomas is controversial. It rarely changes the management of the patients in the initial staging. Recents publications, clinical trials and experts consensus meetings have demonstrated its utility in the evaluation of the response at the end of the treatment. The interest of CT/PET in the evaluation of the response during the treatment, with the objective of implement a "Risk Adapted Therapy", in increasing.</dc:description>
<dc:type>Lectures</dc:type>
<dc:language>es</dc:language>
<dc:date>2012 </dc:date>
<dc:title xml:lang="es">Papel actual del PET-TAC en el linfoma difuso de células B grandes.</dc:title>
<dc:title xml:lang="en">[Present role of CT/PET in diffuse large B-cell lymphoma].</dc:title>
<dc:publisher>Anales de la Real Academia Nacional de Medicina</dc:publisher>
</metadata>
</record>
</pubmed-document>
